Literature DB >> 28042500

MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

Cheng-Jun Sui1, Feng Xu1, Wei-Feng Shen1, Bing-Hua Dai1, Jiong-Jiong Lu1, Min-Feng Zhang1, Jia-Mei Yang1.   

Abstract

Patients with hepatocellular carcinoma (HCC) experience poor prognosis and low survival rates. In this study, we explored the molecular mechanism of microRNA-147 (miR-147) in regulating human HCC. We firstly used quantitative RT-PCR (qRT-PCR) to compare the expression levels of miR-147 between 7 HCC and two normal liver cell lines, as well as 10 paired primary HCC tissues and their adjacent non-carcinoma tissues. We found miR-147 was down-regulated in both HCC cell lines and primary HCCs tissues. HCC cell lines HepG2 and HuH7 were transfected with lentiviral vector of miR-147 mimics. We found overexpressing miR-147 significantly inhibited HCC in vitro proliferation and migration, increased 5-FU chemosensitivity, and reduced in vivo tumorigenicity. Luciferase, qRT-PCR and western blot assays showed that HOXC6 was the downstream target of miR-147, and both gene and protein levels of HOXC6 were down-regulated by miR-147 in HCC cells. SiRNA mediated HOXC6 knockdown inhibited in vitro proliferation and migration, and increased 5-FU chemosensitivity in HCC. On the other hand, HOXC6 overexpression reversed the inhibitory effect of miR-147 on HCC in vitro proliferation. Therefore, our results suggest that miR-147 can modulates HCC development through the regulation on HOXC6.

Entities:  

Keywords:  HOXC6; chemosensitivity; hepatocellular carcinoma; miR-147; migration; proliferation

Year:  2016        PMID: 28042500      PMCID: PMC5199754     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  24 in total

Review 1.  How microRNAs control cell division, differentiation and death.

Authors:  Eric A Miska
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 2.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

Review 3.  MicroRNAs and apoptosis: implications in the molecular therapy of human disease.

Authors:  Bao-Feng Yang; Yan-Jie Lu; Zhi-Guo Wang
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

Review 4.  MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.

Authors:  Nijiro Nohata; Toyoyuki Hanazawa; Takashi Kinoshita; Yoshitaka Okamoto; Naohiko Seki
Journal:  Auris Nasus Larynx       Date:  2012-07-24       Impact factor: 1.863

Review 5.  Effects of HOX homeobox genes in blood cell differentiation.

Authors:  M C Magli; C Largman; H J Lawrence
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

6.  The HOX gene network in hepatocellular carcinoma.

Authors:  Clemente Cillo; Giulia Schiavo; Monica Cantile; Michel P Bihl; Paolo Sorrentino; Vincenza Carafa; Maria D' Armiento; Massimo Roncalli; Sebastiano Sansano; Raffaela Vecchione; Luigi Tornillo; Lucia Mori; Gennaro De Libero; Jessica Zucman-Rossi; Luigi Terracciano
Journal:  Int J Cancer       Date:  2011-05-30       Impact factor: 7.396

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Heike Varnholt; Uta Drebber; Falko Schulze; Inga Wedemeyer; Peter Schirmacher; Hans-Peter Dienes; Margarete Odenthal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 9.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

Review 10.  Systemic therapy of hepatocellular carcinoma: current status and future perspectives.

Authors:  Domenico Germano; Bruno Daniele
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more
  20 in total

1.  Changes in morphology and miRNAs expression in small intestines of Shaoxing ducks in response to high temperature.

Authors:  Yong Tian; Gongqi Li; Xingchen Bu; Junda Shen; Zhengrong Tao; Li Chen; Tao Zeng; Xue Du; Lizhi Lu
Journal:  Mol Biol Rep       Date:  2019-05-02       Impact factor: 2.316

2.  Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4.

Authors:  Shuai Wu; Han Chen; Ling Zuo; Hai Jiang; Hongtao Yan
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

Review 3.  MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.

Authors:  Mehdi Sajjadi-Dokht; Talar Ahmad Merza Mohamad; Heshu Sulaiman Rahman; Marwah Suliman Maashi; Svetlana Danshina; Navid Shomali; Saeed Solali; Faroogh Marofi; Elham Zeinalzadeh; Morteza Akbari; Ali Adili; Ramin Aslaminabad; Majid Farshdousti Hagh; Mostafa Jarahian
Journal:  Genes Dis       Date:  2021-12-03

4.  MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma.

Authors:  Dengdi Hu; Dan Shen; Min Zhang; Nengmeng Jiang; Feng Sun; Shibo Yuan; Kaiming Wan
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

5.  Long Non-coding RNA LINC00847 Induced by E2F1 Accelerates Non-small Cell Lung Cancer Progression Through Targeting miR-147a/IFITM1 Axis.

Authors:  Huan Li; Yao-Kai Chen; Qiu Wan; An-Qi Shi; Min Wang; Ping He; Li-Xin Tang
Journal:  Front Med (Lausanne)       Date:  2021-04-22

6.  Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection.

Authors:  Carolina Stenfeldt; Jonathan Arzt; George Smoliga; Michael LaRocco; Joseph Gutkoska; Paul Lawrence
Journal:  Virol J       Date:  2017-04-07       Impact factor: 4.099

7.  MicroRNA-147 targets BDNF to inhibit cell proliferation, migration and invasion in non-small cell lung cancer.

Authors:  Fang Li; Xianfang Wang; Lingling Yang
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 8.  MiR-147: Functions and Implications in Inflammation and Diseases.

Authors:  Ling Lin; Kebin Hu
Journal:  Microrna       Date:  2021

9.  HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.

Authors:  Pin-Dong Li; Peng Chen; Xin Peng; Charlie Ma; Wen-Jie Zhang; Xiao-Fang Dai
Journal:  Aging (Albany NY)       Date:  2018-01-15       Impact factor: 5.682

10.  Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation.

Authors:  Qi Chen; Qiuping Yin; Yemeng Mao; Zheyu Zhang; Siqi Wu; Zhang Cheng; Xinan Chen; Hanren Xu; Shengming Jin; Haowen Jiang; Chen Yang
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.